Skip to search formSkip to main contentSkip to account menu

interferon beta-1b 0.3 MG Injection [Betaseron]

Known as: INTERFERON BETA-1B 0.3MG/VIL (BETASERON), INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON), Betaseron 0.3 MG Injection 
National Institutes of Health

Related topics

Related topics

10 relations
Albumin Human, USPBetaseronDrug AllergyInjection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
IntroductionPatients with multiple sclerosis (MS) generally undergo long-term treatment with disease-modifying therapies (DMTs… 
Highly Cited
2013
Highly Cited
2013
Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.
Interferon-β (IFN-β) products have been used for many years in the treatment of multiple sclerosis and include recombinant IFN… 
2012
2012
Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency… 
2011
2011
Evaluation of soluble HLA-G as a biomarker for multiple sclerosis
Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I antigen that stands out for its immune regulatory properties… 
2011
2011
Dianas farmacológicas en la esclerosis múltiple
La esclerosis multiple es la enfermedad inflamatoria, desmielinizante y neurodegenerativa cronica mas frecuente en jovenes… 
Highly Cited
2005
Highly Cited
2005
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
2004
2004
Interferon-β-1b
SummaryAbstractInterferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high… 
Review
2004
Review
2004
The pros and cons of early treatment of relapsing forms of multiple sclerosis
Abstract.Cerebral axonal damage and brain atrophy begin at the earliest stages of multiple sclerosis (MS). Progressive neuronal… 
Review
2004
Review
2004
The Official Publication of the Consortium of Multiple Sclerosis Centers and Rehabilitation in Multiple Sclerosis MSInternationalJournal of CARE
s may be submitted to either the general meeting, the International Committee on Databases in MS (ICODIMS) special session (for… 
1986
1986
The isolation of human beta-interferon receptor by wheat germ lectin affinity and immunosorbent column chromatographies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)